Insider Transactions in Q1 2023 at Ambac Financial Group Inc (AMBC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2023
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.13%
|
$1,392
$16.41 P/Share
|
|
Mar 08
2023
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
87
+0.13%
|
-
|
|
Mar 08
2023
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,573
-0.31%
|
$25,168
$16.41 P/Share
|
|
Mar 08
2023
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,573
+0.31%
|
-
|
|
Mar 08
2023
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
348
-0.23%
|
$5,568
$16.41 P/Share
|
|
Mar 08
2023
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
348
+0.23%
|
-
|
|
Mar 08
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.41%
|
$4,816
$16.41 P/Share
|
|
Mar 08
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
301
+0.41%
|
-
|
|
Mar 08
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Exercise of conversion of derivative security
|
Direct |
282
-0.25%
|
$4,512
$16.41 P/Share
|
|
Mar 08
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
282
+0.25%
|
-
|
|
Mar 08
2023
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,572
-3.44%
|
$57,152
$16.41 P/Share
|
|
Mar 08
2023
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,999
+6.31%
|
-
|
|
Feb 28
2023
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-0.26%
|
$20,576
$16.55 P/Share
|
|
Feb 28
2023
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,286
+0.26%
|
-
|
|
Feb 28
2023
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.14%
|
$3,520
$16.55 P/Share
|
|
Feb 28
2023
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
220
+0.14%
|
-
|
|
Feb 28
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Exercise of conversion of derivative security
|
Direct |
178
-0.16%
|
$2,848
$16.55 P/Share
|
|
Feb 28
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
178
+0.16%
|
-
|
|
Feb 28
2023
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.1%
|
$1,136
$16.55 P/Share
|
|
Feb 28
2023
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
71
+0.1%
|
-
|
|
Feb 28
2023
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,891
-22.68%
|
$46,256
$16.55 P/Share
|
|
Feb 28
2023
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,065
+28.41%
|
-
|
|
Feb 28
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.27%
|
$3,136
$16.55 P/Share
|
|
Feb 28
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
196
+0.26%
|
-
|
|
Feb 28
2023
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-2.08%
|
$33,008
$16.55 P/Share
|
|
Feb 28
2023
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,724
+5.47%
|
-
|
|
Feb 22
2023
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,750
-11.46%
|
$140,000
$16.22 P/Share
|
|
Feb 22
2023
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,777
+18.01%
|
-
|
|
Feb 22
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
17,238
-18.98%
|
$275,808
$16.22 P/Share
|
|
Feb 22
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
33,555
+26.97%
|
-
|
|
Feb 22
2023
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,253
-13.73%
|
$388,048
$16.22 P/Share
|
|
Feb 22
2023
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,535
+21.2%
|
-
|
|
Feb 22
2023
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92,709
-15.64%
|
$1,483,344
$16.22 P/Share
|
|
Feb 22
2023
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
180,352
+23.33%
|
-
|
|
Feb 22
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
18,606
-14.29%
|
$297,696
$16.22 P/Share
|
|
Feb 22
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
36,351
+21.82%
|
-
|
|
Feb 22
2023
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
21,489
-18.73%
|
$343,824
$16.22 P/Share
|
|
Feb 22
2023
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,493
+26.56%
|
-
|
|
Jan 02
2023
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,111
-1.93%
|
$137,887
$17.44 P/Share
|
|
Jan 02
2023
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,784
+3.17%
|
-
|
|
Jan 02
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Exercise of conversion of derivative security
|
Direct |
1,579
-1.65%
|
$26,843
$17.44 P/Share
|
|
Jan 02
2023
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,778
+2.83%
|
-
|
|
Jan 02
2023
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
728
-1.21%
|
$12,376
$17.44 P/Share
|
|
Jan 02
2023
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,282
+2.08%
|
-
|
|
Jan 02
2023
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,065
-1.57%
|
$35,105
$17.44 P/Share
|
|
Jan 02
2023
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,633
+2.7%
|
-
|
|
Jan 02
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,457
-2.48%
|
$24,769
$17.44 P/Share
|
|
Jan 02
2023
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,564
+4.18%
|
-
|
|
Jan 02
2023
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,341
-1.8%
|
$22,797
$17.44 P/Share
|
|
Jan 02
2023
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,205
+4.12%
|
-
|